Facebook
Twitter
LinkedIn
Forward
Spotlight on Desmoid Tumors: Bridging Knowledge Gaps for Optimal Patient Care
Overview
Join us for this 1-hour, CME-certified live dinner program to gain expert insights into the evolving treatment landscape for desmoid tumors. In an engaging discussion format, Abhijeet Kumar, MD, and Mahesh Seetharam, MD, FACP, will explore key aspects of desmoid tumor management—including disease pathogenesis, diagnosis, treatment selection, and adverse event management—through patient case discussions and review of the latest clinical data.
Learning Objectives
- Describe evidence-based strategies for the diagnosis of desmoid tumors, including molecular profiling, imaging modalities, and the role of multidisciplinary team consultation.
- Discuss the efficacy, safety, and expected outcomes of standard-of-care therapies with patients under active surveillance considering systemic treatment.
- Develop individualized treatment plans for patients with progressive, unresectable, recurrent, or refractory desmoid tumors based on available clinical data, clinical guidelines, and patient-specific factors.
- Recognize, assess, and manage treatment-related adverse events associated with systemic therapies.
Target Audience
This activity is designed to educate oncology physicians as well as advanced practice providers, physician assistants, pharmacists, and nurse specialists involved in the care of patients with desmoid tumors.
This program is supported by an independent educational grant from SpringWorks Therapeutics, Inc.
Privacy Statement: For online registration, we take precautions to protect your information. When you submit sensitive information via the website, your information is protected both online and offline. In order to use this website, a user must first complete the registration form. During registration, a user is required to give certain information (such as name, email, mailing address, and payment information). This information is confidential and will only be used to contact you regarding your registration.
Please note: times are subject to change. Please check the syllabus for the most current version of the agenda upon arriving at the summit.
Commercial Support: This activity is supported by an independent educational grant from SpringWorks Therapeutics, Inc.
All Times Listed in Local Time Zone
Saturday, July 19, 2025 | |
| 6:15pm | Welcome & Introduction |
| 6:15pm | Spotlight on Desmoid Tumors: Bridging Knowledge Gaps for Optimal Patient Care » Mahesh Seetharam, MD, FACP - Associate Professor of Medicine - Mayo Clinic College of Medicine and Science - Phoenix, AZ » Abhijeet Kumar, M.D. - Associate Professor, = University of Arizona Cancer Center - Tucson, Arizon |
| 7:15pm | Closing Remarks |
Faculty
Mahesh Seetharam, MD, FACP
Associate Professor of Medicine
Mayo Clinic College of Medicine and Science
Phoenix, AZ
Dr. Mahesh Seetharam is a hematologist and oncologist at the Mayo Clinic in Phoenix, Arizona. He currently serves as a Consultant in the Division of Hematology/Oncology and as an Associate Professor of Medicine at the Mayo Clinic College of Medicine and Science.
Dr. Seetharam earned his MBBS from Mysore Medical College in India before continuing medical training in the United Kingdom and the United States. His postgraduate training included residencies and fellowships at the National Cancer Institute, Albert Einstein College of Medicine, and Stanford University Hospital. He is board-certified in Internal Medicine, Hematology, and Medical Oncology.
His clinical and research expertise focuses on sarcomas and cutaneous oncology, where he has played a pivotal role in expanding the sarcoma program at Mayo Clinic Arizona. Under his leadership, the sarcoma program has grown into a premier referral center, offering multidisciplinary care and a robust clinical trial portfolio. Dr. Seetharam also leads initiatives in cutaneous cancers.
Beyond his clinical and research contributions, Dr. Seetharam is involved in medical education, mentoring medical students, residents, and fellows. He has held leadership roles in various professional organizations, including the Arizona Clinical Oncology Society (TACOS).
Dr. Seetharam’s work is widely recognized, with numerous publications, conference presentations, and roles as an ad hoc reviewer for multiple journals.
Abhijeet Kumar, M.D.
Associate Professor,
University of Arizona Cancer Center
Tucson, Arizona
Abhijeet Kumar, MD is an Associate Professor of Medicine (Clinical Scholar Track) at the University of Arizona Cancer Center. He received his MBBS at the Sikkim Manipal Institute of Medical Sciences in India and completed his internship at the Central Referral Hospital in Gangtok and Pakyong Rural Health Center in Sikkim, India. Dr. Kumar completed his residency at St. Agnes Hospital, Internal Medicine and fellowship at University of Arizona, Hematology and Oncology.
Dr. Kumar is a member of the American Society of Clinical Oncology, American Society of Hematology, American College of Physicians and Medical Council of India. With several research papers published, he serves on the editorial board for Gastrointestinal Cancer: Research & Therapy Journal.
He is focused on lymphomas, non-Hodgkin and hodgkin and chronic lymphocytic leukemia. He is also focused on sarcomas. He received the Bressler-Alpert Travel Award in 2016 and was Chief Resident 2013-2014 and Intern of the Year 2011-2012.
Disclosures
Horizon CME requires all planners, faculty, and other contributors to disclose any financial relationships with an ACCME defined ineligible company within the past 24 months and Horizon CME has resolved any conflicts prior to this educational activity.
Planners
*Horizon CME has mitigated and resolved all relevant financial relationships
Faculty *
Mahesh Seetharam, MD, FACP discloses advisory boards with Springwork Therapeutic during the past 24 months.
Abhijeet Kumar, M.D. discloses advisory boards with ADC therapeutics , Astra Zeneca during the past 24 months.
Those others involved in the planning of this activity disclosed no relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Other Contributors *
All other non-faculty contributors and others involved in the planning, development and editing/review of the content disclosed no relevant financial relationships with any entity producing, marketing, re-selling or distributing health care goods or services consumed by or used on patients.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.
Horizon CME designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.